language_icon
EN
HI

Healthcare Global Enterprises Share price

HCG

531.8

4.00 (-0.75%)
NSE
BSE
Last updated on 27 Mar, 2026 | 15:31 IST
Today's High

537.95

Today's Low

519.00

52 Week Low

496.29

52 Week High

796.68

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Healthcare Global Enterprises Chart

Healthcare Global Enterprises Share Key Metrics

Volume
3.92 L
Market Cap
7939.89 CR
LTQ@LTP
85@531.80
ATP
527.46
Var Margin
16.37 %
Circuit Range
428.65-642.95
Delivery %
60.98 %
Value
20.69 CR
ASM/GSM
No
Market Lot
1

Summary

At 27 Mar, 2026 | 15:31, Healthcare Global Enterprises share price stands at ₹531.8, showing a 4.00% -0.75 for the day. The stock’s intraday movement has stayed between ₹519.00 and ₹537.95, while on a 52-week basis it has fluctuated from ₹496.29 to ₹796.68.
In terms of trading activity, Healthcare Global Enterprises has recorded a volume of 392215 shares, with a market capitalisation of ₹149302204. The stock’s Average Traded Price (ATP) stands at ₹52746, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 85,53180. The stock operates within a circuit range of ₹428.65-642.95, with a Value of ₹20.69 CR. The Delivery Percentage for the day is 60.98%. Additionally, Healthcare Global Enterprises currently falls under the No framework, and trades with a market lot size of 1.

Healthcare Global Enterprises Fundamentals

View More
P/E Ratio

422.73

P/B Ratio

5.99

Div. Yield

0

Sector P/E

48.66

Sector P/B

-16.66

Sec. Div. Yield

2.58

Healthcare Global Enterprises Resistance and Support

Pivot 536.55

Resistance

First Resistance

543.1

Second Resistance

550.4

Third Resistance

556.95

Support

First Support

529.25

Second Support

522.7

Third Support

515.4

Healthcare Global Enterprises Futures & Options

Data Not Found

Healthcare Global Enterprises Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

63.77%

Mutual Fund

15.08%

Insurance

0.54%

Foreign Institutional Investors

3.22%

Domestic Institutional Investors

2.68%

Retail

14.71%

Others

0%

Total Promoters
MAR '25
71.22%
JUN '25
62.46%
SEP '25
63.78%
DEC '25
63.77%

Healthcare Global Enterprises Corporate Actions

DateAgenda
2026-02-17Rights issue of Equity Shares
2026-02-05Quarterly Results
2025-11-12Quarterly Results
2025-08-01Quarterly Results
2025-05-24Audited Results
2025-02-14Quarterly Results & Others
2025-02-13Quarterly Results & Others

Healthcare Global Enterprises News

HealthCare Global Enterprises Ltd - 539787 - Outcome Of Rights Issue Committee- March 27, 2026

HealthCare Global allotted 8.29 million equity shares at ₹512 per share through its rights issue. This increases the company's paid-up equity capital from ₹141.01 crore to ₹149.30 crore.
Mar 27 2026 22:03:00

HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Allotment

HealthCare Global allotted 8.29 million equity shares at ₹512 per share through its rights issue. This increases the company's paid-up equity capital from ₹141.01 crore to ₹149.30 crore.
Mar 27 2026 22:03:00
Read More

About Healthcare Global Enterprises

NSE : 15555  
BSE : 539787  
ISIN : INE075I01017  

The Company was originally incorporated as Curie Centre of Oncology Private Limited on March 12 1998 at Bengaluru Karnataka India as a private limited company under the Companies Act 1956. The name of the Company was subsequently changed to HealthCare Global Enterprises Private Limited and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on November 14 2005. the Company was converted into a public limited company pursuant to a special resolution passed by the Shareholders at the EGM held on May 20 2006 and the name of the Company was changed to HealthCare Global Enterprises Limited. A fresh certificate of incorporation consequent upon conversion to a public limited company was issued by the RoC on July 5 2006. Major events and milestones of the Company :2005-Entered into the clinical laboratory business through acquisition of Triesta Sciences Inc. and Triesta Sciences (India) Private Limited 2006-India Development Fund made its first investment of 500 million in the Company -BMORCL became the Subsidiary 2007-HCG Medi-Surge became the Subsidiary -Evolvence made its first investment of 225 million in the Company 2008-NTICPL made its first investment of 400 million in the Company 2009-Amalgamation of Triesta Sciences (India) Private Limited and Triesta Sciences Inc. with the Company 2010-IL&FS Trust Company Limited a/c MPEF through its scheme India Build Out Fund I and MAT made its first investment of 312 million in the Company 2011-Amalgamation of BMORCL with the Company -PIOF became a Shareholder by purchasing shares from NTICPL 2013-V-Sciences made its first investment of `600 million in the Company -Entered into the fertility business through acquisition of 50.10% stake in BACC Healthcare 2014-Demerger of multispecialty division from HCG Medi-Surge and vesting of the same with the Company 2015-HCG Regency became the Subsidiary -Amalgamation of HCG Vijay with the Company

Read More

Healthcare Global Enterprises Management

NamePosition
Dr. B S Ajai Kumar Executive Chairman
Dr. Manish Mattoo Executive Director & CEO
View More

Healthcare Global Enterprises FAQs

The Buying Price of Healthcare Global Enterprises share is 531.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Healthcare Global Enterprises stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Healthcare Global Enterprises, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Healthcare Global Enterprises shares is 422.73. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Healthcare Global Enterprises shares is 5.99. Useful to assess the stock's value relative to its book value.

To assess Healthcare Global Enterprises’s valuation compare Sector P/E, P/B which are 48.66 & -16.66 with sector averages, along with growth rates and financial metrics.

The Market Cap of Healthcare Global Enterprises is 7939.89 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Healthcare Global Enterprises share price is 796.68 & 496.29. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Healthcare Global Enterprises belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost